These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 11103598)
21. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
22. WHO enlisted to break deadlock over drug-access agreement. AIDS Policy Law; 2003 Jan; 18(2):6. PubMed ID: 12599302 [No Abstract] [Full Text] [Related]
23. Management of quality, capacity, and productivity at Merck. Nathan J; Venkataraman R Hosp Mater Manage Q; 1999 Feb; 20(3):64-9. PubMed ID: 10345635 [TBL] [Abstract][Full Text] [Related]
24. [An alternative and innovative Research and Development model to ensure access to medicines - Neglected diseases, neglected populations, and biomedical innovation system]. Pécoul B Med Sci (Paris); 2016 Dec; 32(12):1049-1050. PubMed ID: 28044961 [No Abstract] [Full Text] [Related]
25. WHO and industry combine to form ethics body. Dickson D Nat Med; 2002 Jul; 8(7):645. PubMed ID: 12091885 [No Abstract] [Full Text] [Related]
26. Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Caudron JM; Ford N; Henkens M; Macé C; Kiddle-Monroe R; Pinel J Trop Med Int Health; 2008 Aug; 13(8):1062-72. PubMed ID: 18631318 [TBL] [Abstract][Full Text] [Related]
27. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR]. Temprano G; Prats S; Bregni C Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947 [TBL] [Abstract][Full Text] [Related]
28. [Update of a database on plants involved in the composition of 825 drugs: Pharmaplantes-Kénitra 98]. Choulli MK; Quyou A; Ait Aguil F; Rmouch H Therapie; 1999; 54(6):741-6. PubMed ID: 10709450 [TBL] [Abstract][Full Text] [Related]
31. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction. Cohen JC; Mrazek M; Hawkins L Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983 [TBL] [Abstract][Full Text] [Related]
32. [Various aspects of the significance of government control in drug supply]. Teijgeler CA; Samsom RJ Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999 [No Abstract] [Full Text] [Related]
33. [Surgical congresses--are there too many? From the viewpoint of the Federal Association of the Pharmaceutical Industry]. Vogel HR Chirurg; 1995 Feb; 66(2):suppl 32-4. PubMed ID: 7712849 [No Abstract] [Full Text] [Related]
34. What is quality of medicines? Doogue MP; Thynne TR Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167 [No Abstract] [Full Text] [Related]
35. The morally uncomfortable global drug gap. Cohen-Kohler JC Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710 [TBL] [Abstract][Full Text] [Related]
36. Implications of bilateral free trade agreements on access to medicines. Correa CM Bull World Health Organ; 2006 May; 84(5):399-404. PubMed ID: 16710551 [TBL] [Abstract][Full Text] [Related]
37. GATT and the gap: how to save lives. James JS AIDS Treat News; 1998 Nov; (No 307):1, 3-6. PubMed ID: 11366123 [TBL] [Abstract][Full Text] [Related]
38. Access to medicines report cards. Mullard A Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336 [No Abstract] [Full Text] [Related]
39. A clarification on global access to drugs. Rys A Science; 2007 Feb; 315(5814):939-40. PubMed ID: 17303736 [No Abstract] [Full Text] [Related]
40. Innovation and the WHO's essential medicines list: giving credit where credit is due. Wertheimer AI; Santella TM Res Social Adm Pharm; 2007 Mar; 3(1):137-44. PubMed ID: 17350562 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]